Novosteo

Founded to reduce the morbidity, mortality and loss of productivity associated with bone fractures.

Launch date

2017

Employees

Market cap

Enterprise valuation

West Lafayette Indiana (HQ)

Date	Investors	Amount	Round
Sep 2018	National Institutes of Health	$1.7m	Grant
Aug 2019	Research Bridge Partners	$500k	Seed
Feb 2021	BioCrossroads Purdue Research Foundation Elevate Ventures Kairos Ventures	$5.5m	Series A
May 2022*	Quince Therapeutics	N/A	Acquisition
Total Funding		€7.0m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Novosteo